Latest News

Image description

Worry-Free Medicare Audits

Increased Medicare audits are raising the stakes for compliance in today’s pharmacies, with stricter enforcement than ever before. In fact, the likelihood of receiving a Part B audit request continues to climb amid national efforts to control fraud, waste and abuse.

Image description

Nielsen: Dollar store, C-store expansions changing retail landscape

CHICAGO - Consumers flocked to more than 6,100 new retail stores that opened across the U.S. between December 2013 and December 2015, Nielsen reported Wednesday. And while grocery stores and supercenters still drive the bulk of consumer packaged goods sales, dollar stores and convenience centers are leading in store expansion. Together, dollar stores and C-stores represented more than 87% of the total new store openings, Nielsen reported. "On one end of the spectrum, discount retailers are expected to rise, as value is driving consumers to search for the biggest bang for their buck. On the other end, retailers with premium products ... will continue to attract and retain those consumers." (Nielsen)
 

Image description

NuGo Nutrition acquires ProMax sports nutrition bars

OAKMONT, Pa. - NuGo Nutrition, a fast-growing lifestyle brand in the natural foods category known for creating protein bars for several lifestyles, on Wednesday announced it has acquired the sports performance brand, Promax from Promax Nutrition Corporation.

Terms of the transaction were not disclosed.

Image description

WSJ: FDA inspection scuttles Theranos' Zika-virus emergency clearance request

Theranos is facing its latest crisis following its withdrawal of its request for emergency clearance of a Zika-virus blood test after federal regulators found that the company didn’t include proper patient safeguards in a study of the new test, The Wall Street Journal reported Tuesday, citing people familiar with the matter. "Theranos founder Elizabeth Holmes announced Aug. 1 a new blood-testing device called miniLab that she said was designed for use outside a clinical laboratory and could run accurate tests from a few drops of blood," The Journal wrote. "But during an inspection by the FDA earlier this month, regulators concluded that Theranos had collected some data supporting the accuracy of the Zika test without implementing a patient-safety protocol approved by an institutional review board." (The Wall Street Journal)